2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bayesian sample size determination using commensurate priors to leverage preexperimental data

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This paper develops Bayesian sample size formulae for experiments comparing two groups, where relevant preexperimental information from multiple sources can be incorporated in a robust prior to support both the design and analysis. We use commensurate predictive priors for borrowing of information and further place Gamma mixture priors on the precisions to account for preliminary belief about the pairwise (in)commensurability between parameters that underpin the historical and new experiments. Averaged over the probability space of the new experimental data, appropriate sample sizes are found according to criteria that control certain aspects of the posterior distribution, such as the coverage probability or length of a defined density region. Our Bayesian methodology can be applied to circumstances that compare two normal means, proportions, or event times. When nuisance parameters (such as variance) in the new experiment are unknown, a prior distribution can further be specified based on preexperimental data. Exact solutions are available based on most of the criteria considered for Bayesian sample size determination, while a search procedure is described in cases for which there are no closed‐form expressions. We illustrate the application of our sample size formulae in the design of clinical trials, where pretrial information is available to be leveraged. Hypothetical data examples, motivated by a rare‐disease trial with an elicited expert prior opinion, and a comprehensive performance evaluation of the proposed methodology are presented.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: not found
          • Book: not found

          Bayesian Data Analysis

            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            Bayesian Approaches to Clinical Trials and Health-Care Evaluation

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Bayesian methods for the design and interpretation of clinical trials in very rare diseases

              This paper considers the design and interpretation of clinical trials comparing treatments for conditions so rare that worldwide recruitment efforts are likely to yield total sample sizes of 50 or fewer, even when patients are recruited over several years. For such studies, the sample size needed to meet a conventional frequentist power requirement is clearly infeasible. Rather, the expectation of any such trial has to be limited to the generation of an improved understanding of treatment options. We propose a Bayesian approach for the conduct of rare-disease trials comparing an experimental treatment with a control where patient responses are classified as a success or failure. A systematic elicitation from clinicians of their beliefs concerning treatment efficacy is used to establish Bayesian priors for unknown model parameters. The process of determining the prior is described, including the possibility of formally considering results from related trials. As sample sizes are small, it is possible to compute all possible posterior distributions of the two success rates. A number of allocation ratios between the two treatment groups can be considered with a view to maximising the prior probability that the trial concludes recommending the new treatment when in fact it is non-inferior to control. Consideration of the extent to which opinion can be changed, even by data from the best feasible design, can help to determine whether such a trial is worthwhile. © 2014 The Authors. Statistics in Medicine published by John Wiley & Sons, Ltd.
                Bookmark

                Author and article information

                Contributors
                haiyan.zheng@mrc-bsu.cam.ac.uk
                Journal
                Biometrics
                Biometrics
                10.1111/(ISSN)1541-0420
                BIOM
                Biometrics
                John Wiley and Sons Inc. (Hoboken )
                0006-341X
                1541-0420
                28 March 2022
                June 2023
                : 79
                : 2 ( doiID: 10.1111/biom.v79.2 )
                : 669-683
                Affiliations
                [ 1 ] MRC Biostatistics Unit University of Cambridge Cambridge UK
                [ 2 ] Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK
                [ 3 ] Department of Mathematics and Statistics Lancaster University Lancaster UK
                Author notes
                [*] [* ] Correspondence

                Haiyan Zheng, MRC Biostatistics Unit, University of Cambridge, Cambridge, CB2 0SR, UK.

                Email: haiyan.zheng@ 123456mrc-bsu.cam.ac.uk

                Author information
                https://orcid.org/0000-0002-3385-2117
                https://orcid.org/0000-0002-4691-126X
                Article
                BIOM13649
                10.1111/biom.13649
                10952893
                35253201
                0cb6d81f-d212-4ca8-8639-e950f9b1c319
                © 2022 The Authors. Biometrics published by Wiley Periodicals LLC on behalf of International Biometric Society.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 08 March 2021
                : 23 February 2022
                Page count
                Figures: 4, Tables: 1, Pages: 15, Words: 7784
                Funding
                Funded by: Medical Research Council , doi 10.13039/501100000265;
                Award ID: MC_UU_00002/6
                Award ID: MC_UU_00002/14
                Funded by: Cancer Research UK , doi 10.13039/501100000289;
                Award ID: RCCPDF∖100008
                Funded by: National Institute for Health Research , doi 10.13039/501100000272;
                Award ID: NIHR‐SRF‐2015‐08‐001
                Categories
                Biometric Methodology
                Biometric Methodology
                Custom metadata
                2.0
                June 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:20.03.2024

                Biostatistics
                bayesian experimental designs,historical data,rare‐disease trials,robustness,sample size

                Comments

                Comment on this article